Russia appears to be the headline in Vaccine reports after the UK and U.S. topped the vaccine issue. Russia today announced that it will issue a vaccine that has high efficacy.
Tuesday's report states that scientists have confirmed that the Russian vaccine Sputnik V has almost 92% effectiveness in combating Covid-19 based on the final test results published in the international medical journal The Lancet.
Experts argue that the results of the level III trial illustrate that the world now has another effective weapon to fight the deadly pandemic. Experts also confirm that the results of the data are legit.
According to professors at the University of Reading and London School of Hygiene & Tropical Medicine, Ian Jones and Polly Roy, the results reported are clear and follow the set standards.
The results of the effectiveness are based on data collected from 19,866 volunteers. Since the initial trial was conducted in Moscow, only 16 cases of Covid-19 have symptoms among vaccine recipients and 62 in the placebo group.
The current market focus is no longer tied to vaccine effectiveness reports but is more focused on practicality issues such as cost, logistics and vaccine distribution.
